Natasha Hernday
Director, PDL BIOPHARMA, INC.
Companies
- Janux Therapeutics, Inc.Board member Jul 22, 2024 to now1
- XOMA Royalty CorpBoard member Jul 2, 2020 to now2
- Alpine Immune SciencesBoard member Dec 11, 2020 to May 20, 20243
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Janux Therapeutics, Inc. JANX15,481 shares4$257.0K at $16.60Jun 11, 2026
- XOMA Royalty Corp0 shares5Jul 14, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 14, 2026Returned to company 4,000 shares of XOMA Royalty Corp5
- Jul 14, 2026Other 9,304 shares of XOMA Royalty Corp5
- Jun 11, 2026Granted 5,500 shares of Janux Therapeutics, Inc.4
- May 21, 2026Granted 3,586 shares of XOMA Royalty Corp6
- Jun 11, 2025Granted 3,750 shares of Janux Therapeutics, Inc.7
- May 21, 2025Granted 5,971 shares of XOMA Royalty Corp8
- Jul 19, 2024Granted 2,500 shares of Janux Therapeutics, Inc.9
- Jul 19, 2024Granted 1,231 shares of Janux Therapeutics, Inc.10
- Jul 19, 2024Granted 5,000 shares of Janux Therapeutics, Inc.9
- May 15, 2024Granted 3,035 shares of XOMA Royalty Corp11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARXOMA Royalty Corp, Board member
- 3SEC EDGARAlpine Immune Sciences, Board member
- 4
- 5
- 6SEC EDGARForm 4 filed May 26, 2026
- 7SEC EDGARForm 4 filed Jun 13, 2025
- 8SEC EDGARForm 4 filed May 23, 2025
- 9SEC EDGARForm 4 filed Jul 22, 2024
- 10SEC EDGARForm 4 filed Jul 24, 2024
- 11SEC EDGARForm 4 filed May 17, 2024